Olanzapin in the Treatment of a Somatoform Disorder;Olanzapin in der Therapie einer somatoformen Störung

Psychiatrische Praxis

Volumn 30, Issue 8, 2003, Pages 450-451

  Kozian, Ralf ^a  

^a Landesklinik Brandenburg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; GABAPENTIN; OLANZAPINE; TOPIRAMATE;

ARTICLE; DOSE RESPONSE; DRUG EFFICACY; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REMISSION; SOMATOFORM DISORDER; TREATMENT OUTCOME; TREATMENT PLANNING;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CHEST PAIN; CLOMIPRAMINE; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FATIGUE; HUMANS; MALE; MIDDLE AGED; PAIN; SCALP; SOMATOFORM DISORDERS;

EID: 0346251350     PISSN: 03034259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Hessel A, Geyer M, Schumacher J, Brahler E. Somatoforme Beschwerden in der Bevölkerung Deutschlands. Z Psychosom Med Psychother 2002; 48: 38-58
2. Ladwig KH, Marten-Mittag B, Erazo N, Gundel H. Identifying somatization disorder in a population based health examination survey: psychosocial burden and gender differences. Psychosomatics 2001; 42: 511-518
3. Maier W. Angst- und Somatisierungsstörungen. Fortschr Neurol Psychiat 1998; 66 (Sonderheft 1): S3-S8
4. Menza M, Lauritano M, Allen L, Warman M, Ostella F, Hamer RM, Escobar J. Treatment of somatization disorder with nefazodone: a prospective, open-label study. Ann Clin Psychiatry 2001; 13: 153-158
5. Noyes R Jr, Happel RL, Muller BA, Holt CS, Kathol RG, Sieren LR, Amos JJ. Fluvoxamine for somatoform disorders: an open trial. Gen Hosp Psychiatry 1998; 20: 339-344
6. Garcia-Campayo J, Sanz-Carrillo C. Gabapentine for the treatment of patients with somatization disorder. J Clin Psychiatry 2001; 62: 474
7. Garcia-Campayo J, Sanz-Carrillo C. Topiramate as a treatment for pain in multisomatoform disorder patients: an open trial. Gen Hosp Psychiatry 2002; 24: 417-421
8. Volz HP, Möller HJ, Reimann I, Stoll KD. Opipramol for the treatment of somatoform disorders results from a placebo-controlled trail. Eur Neuropsychopharmacol 2000; 10: 211-217
9. Rouillon F, Rahola G, Moffaert M van, Lopes RG, Dunia I. Sulpiride in the treatment of somatoform disorders: results of a European observational study to characterize the responder profile. J Int Med Research 2001; 29: 304-313
10. Grant JE. Succesful treatment of nondelusional body dismorphic disorder with olanzapine: a case report. J Clin Psychiatry 2001; 62: 297-298
11. Schreiber S, Getslev V, Backer MM, Weizman R, Pick CG. The atypical neuroleptics clozapine and olanzapine differ regarding their antinociceptive mechanisms and potency. Pharmacology Biochemistry and Behavior 1999; 64: 75-80